4/1～4/11の期間におけるオーストラリアTGAからのCOVID-19絡みの措置（一時的なものを含む）が通知されています。
ただ、GMP Platform読者に関係しそうなものだけを取り上げていますことをご容赦ください。
詳細については、下記URLsの通知をご参照ください。
l4/11付「COVID-19 test kits included on the ARTG for legal supply in Australia」
https://www.tga.gov.au/covid-19-test-kits-included-artg-legal-supply-australia
l4/11付「Expedited recall system for faulty or unauthorised COVID-19 devices」
https://www.tga.gov.au/behind-news/expedited-recall-system-faulty-or-unauthorised-covid-19-devices
l4/8付「Manufacturing medical devices for COVID-19 including 3-D printing」
https://www.tga.gov.au/manufacturing-medical-devices-covid-19-including-3-d-printing
l4/8付「Exemption to enable the domestic manufacture and supply of ventilators」
https://www.tga.gov.au/exemption-enable-domestic-manufacture-and-supply-ventilators
l4/7付「Ventilator for COVID-19 use in Australia」
https://www.tga.gov.au/ventilator-covid-19-use-australia
l4/7付「COVID-19 point-of-care tests」
https://www.tga.gov.au/covid-19-point-care-tests
l4/7付「Amendments to the new restrictions on prescribing hydroxychloroquine for COVID-19」
https://www.tga.gov.au/alert/amendments-new-restrictions-prescribing-hydroxychloroquine-covid-19
l4/3付「Notice of an amendment to the current Poisons Standard under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989 - Hydroxychloroquine」
https://www.tga.gov.au/scheduling-decision-final/notice-amendment-current-poisons-standard-under-paragraph-52d2a-therapeutic-goods-act-1989-hydroxychloroquine
l4/2付「TGA collaborating to help ensure the supply of ventilators」
https://www.tga.gov.au/tga-collaborating-help-ensure-supply-ventilators
l4/1付「Warning to consumers and advertisers about COVID-19 test kits」
https://www.tga.gov.au/media-release/warning-consumers-and-advertisers-about-covid-19-test-kits
ただ、GMP Platform読者に関係しそうなものだけを取り上げています
詳細については、下記URLsの通知をご参照ください。
l4/11付「COVID-19 test kits included on the ARTG for legal supply in Australia」
https://www.tga.gov.au/covid-
l4/11付「Expedited recall system for faulty or unauthorised COVID-19 devices」
https://www.tga.gov.au/behind-
l4/8付「Manufacturing medical devices for COVID-19 including 3-D printing」
https://www.tga.gov.au/
l4/8付「Exemption to enable the domestic manufacture and supply of ventilators」
https://www.tga.gov.au/
l4/7付「Ventilator for COVID-19 use in Australia」
https://www.tga.gov.au/
l4/7付「COVID-19 point-of-care tests」
https://www.tga.gov.au/covid-
l4/7付「Amendments to the new restrictions on prescribing hydroxychloroquine for COVID-19」
https://www.tga.gov.au/alert/
l4/3付「Notice of an amendment to the current Poisons Standard under paragraph 52D(2)(a) of the Therapeutic Goods Act 1989 - Hydroxychloroquine」
https://www.tga.gov.au/
l4/2付「TGA collaborating to help ensure the supply of ventilators」
https://www.tga.gov.au/tga-
l4/1付「Warning to consumers and advertisers about COVID-19 test kits」
https://www.tga.gov.au/media-
執筆者について
経歴 ※このプロフィールは掲載記事執筆時点での内容となります
コメント
/
/
/
コメント